<html><head><title>Last Compo RA CAPITAL MANAGEMENT, L.P.</title></head><link rel="stylesheet" type="text/css" href="alphaleague_style.css"/>
                  <body><h2>RA CAPITAL MANAGEMENT, L.P.<br>#assets : 70<br>AUMs(M$) : 5,467</h2><table border="1" class="dataframe mystyle">
  <thead>
    <tr style="text-align: center;">
      <th></th>
      <th>name</th>
      <th>rpt_dt</th>
      <th>w</th>
      <th>name_prev</th>
      <th>rpt_dt_prev</th>
      <th>w_prev</th>
      <th>dw</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>04351P101</th>
      <td>ASCENDIS PHARMA A S</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">16.6</div></td>
      <td>ASCENDIS PHARMA A S</td>
      <td>30June20</td>
      <td>14.1</td>
      <td><div p style="color:black;background:#dbfad2;">2.5</div></td>
    </tr>
    <tr>
      <th>34633R104</th>
      <td>FORMA THERAPEUTICS HLDGS INC</td>
      <td>30September20</td>
      <td>8.2</td>
      <td>FORMA THERAPEUTICS HLDGS INC</td>
      <td>30June20</td>
      <td>8.1</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>16383L106</th>
      <td>CHEMOCENTRYX INC</td>
      <td>30September20</td>
      <td>4.8</td>
      <td>CHEMOCENTRYX INC</td>
      <td>30June20</td>
      <td>5.4</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>92243G108</th>
      <td>VAXCYTE INC</td>
      <td>30September20</td>
      <td>4.7</td>
      <td>VAXCYTE INC</td>
      <td>30June20</td>
      <td>3.3</td>
      <td>1.4</td>
    </tr>
    <tr>
      <th>88322Q108</th>
      <td>TG THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>4.3</td>
      <td>TG THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>4.8</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>65487U108</th>
      <td>NKARTA INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">3.0</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">3.0</div></td>
    </tr>
    <tr>
      <th>05464T104</th>
      <td>AXSOME THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>2.6</td>
      <td>AXSOME THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>3.2</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>71722W107</th>
      <td>PHATHOM PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>2.5</td>
      <td>PHATHOM PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>2.4</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>81750R102</th>
      <td>SERES THERAPEUTICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">2.4</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">2.4</div></td>
    </tr>
    <tr>
      <th>670002401</th>
      <td>NOVAVAX INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#f5d2ce;">2.3</div></td>
      <td>NOVAVAX INC</td>
      <td>30June20</td>
      <td>7.7</td>
      <td><div p style="color:black;background:#f5d2ce;">-5.4</div></td>
    </tr>
    <tr>
      <th>282559103</th>
      <td>89BIO INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>89BIO INC</td>
      <td>30June20</td>
      <td>1.2</td>
      <td>1.0</td>
    </tr>
    <tr>
      <th>556099109</th>
      <td>MACROGENICS INC</td>
      <td>30September20</td>
      <td>2.0</td>
      <td>MACROGENICS INC</td>
      <td>30June20</td>
      <td>2.4</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>76243J105</th>
      <td>RHYTHM PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>2.0</td>
      <td>RHYTHM PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>2.2</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>46565G104</th>
      <td>ITEOS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.9</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.9</td>
    </tr>
    <tr>
      <th>28249H104</th>
      <td>EIDOS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.9</td>
      <td>EIDOS THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>2.0</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>00773U108</th>
      <td>ADVERUM BIOTECHNOLOGIES INC</td>
      <td>30September20</td>
      <td>1.7</td>
      <td>ADVERUM BIOTECHNOLOGIES INC</td>
      <td>30June20</td>
      <td>3.1</td>
      <td>-1.4</td>
    </tr>
    <tr>
      <th>98978L204</th>
      <td>ZOGENIX INC</td>
      <td>30September20</td>
      <td>1.7</td>
      <td>ZOGENIX INC</td>
      <td>30June20</td>
      <td>1.9</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>89620X506</th>
      <td>TRILLIUM THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.6</td>
      <td>TRILLIUM THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.9</td>
      <td>0.7</td>
    </tr>
    <tr>
      <th>00653A107</th>
      <td>ADAPTIMMUNE THERAPEUTICS PLC</td>
      <td>30September20</td>
      <td>1.6</td>
      <td>ADAPTIMMUNE THERAPEUTICS PLC</td>
      <td>30June20</td>
      <td>2.5</td>
      <td>-0.9</td>
    </tr>
    <tr>
      <th>761299106</th>
      <td>RETROPHIN INC</td>
      <td>30September20</td>
      <td>1.5</td>
      <td>RETROPHIN INC</td>
      <td>30June20</td>
      <td>1.8</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>04335A105</th>
      <td>ARVINAS INC</td>
      <td>30September20</td>
      <td>1.5</td>
      <td>ARVINAS INC</td>
      <td>30June20</td>
      <td>2.4</td>
      <td>-0.9</td>
    </tr>
    <tr>
      <th>483119103</th>
      <td>KALA PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>1.4</td>
      <td>KALA PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>2.2</td>
      <td>-0.8</td>
    </tr>
    <tr>
      <th>09203E105</th>
      <td>BLACK DIAMOND THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.4</td>
      <td>BLACK DIAMOND THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>2.1</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>492327101</th>
      <td>KEROS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>KEROS THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.3</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>449585108</th>
      <td>IGM BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>IGM BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>1.3</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>92243A200</th>
      <td>VAXART INC</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.3</td>
    </tr>
    <tr>
      <th>52490G102</th>
      <td>LEGEND BIOTECH CORP</td>
      <td>30September20</td>
      <td>1.3</td>
      <td>LEGEND BIOTECH CORP</td>
      <td>30June20</td>
      <td>2.0</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>Y95308105</th>
      <td>WAVE LIFE SCIENCES LTD</td>
      <td>30September20</td>
      <td>1.2</td>
      <td>WAVE LIFE SCIENCES LTD</td>
      <td>30June20</td>
      <td>1.5</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>69353Y103</th>
      <td>PMV PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.1</td>
    </tr>
    <tr>
      <th>26818M108</th>
      <td>DYNE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>1.0</td>
    </tr>
    <tr>
      <th>45790W108</th>
      <td>INOZYME PHARMA INC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.9</td>
    </tr>
    <tr>
      <th>374163103</th>
      <td>GERON CORP</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>GERON CORP</td>
      <td>30June20</td>
      <td>1.2</td>
      <td>-0.3</td>
    </tr>
    <tr>
      <th>68570P101</th>
      <td>ORCHARD THERAPEUTICS PLC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>ORCHARD THERAPEUTICS PLC</td>
      <td>30June20</td>
      <td>0.8</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>00973J101</th>
      <td>AKOUOS INC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>AKOUOS INC</td>
      <td>30June20</td>
      <td>1.0</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>14147L108</th>
      <td>CARDIFF ONCOLOGY INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.8</td>
    </tr>
    <tr>
      <th>45720L107</th>
      <td>INHIBRX INC</td>
      <td>30September20</td>
      <td>0.7</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.7</td>
    </tr>
    <tr>
      <th>75943R102</th>
      <td>RELAY THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.7</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.7</td>
    </tr>
    <tr>
      <th>22663K107</th>
      <td>CRINETICS PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>CRINETICS PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.7</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>03969K108</th>
      <td>ARCUTIS BIOTHERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>ARCUTIS BIOTHERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.6</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>039697107</th>
      <td>ARDELYX INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>ARDELYX INC</td>
      <td>30June20</td>
      <td>0.8</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>014442107</th>
      <td>ALECTOR INC</td>
      <td>30September20</td>
      <td>0.6</td>
      <td>ALECTOR INC</td>
      <td>30June20</td>
      <td>1.9</td>
      <td>-1.3</td>
    </tr>
    <tr>
      <th>75955J402</th>
      <td>RELMADA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>RELMADA THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.7</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>925050106</th>
      <td>VERONA PHARMA PLC</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>810648105</th>
      <td>SCPHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>SCPHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.5</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>45253H101</th>
      <td>IMMUNOGEN INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>517125100</th>
      <td>LARIMAR THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>LARIMAR THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.3</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>206022105</th>
      <td>CONCERT PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>CONCERT PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.3</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>869367102</th>
      <td>SUTRO BIOPHARMA INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>SUTRO BIOPHARMA INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>80405P107</th>
      <td>SATSUMA PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#f5d2ce;">0.3</div></td>
      <td>SATSUMA PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>2.6</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.3</div></td>
    </tr>
    <tr>
      <th>698340106</th>
      <td>PANDION THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>59935V107</th>
      <td>MILESTONE PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>74140Y101</th>
      <td>PREVAIL THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>PREVAIL THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.7</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>67576A100</th>
      <td>OCULAR THERAPEUTIX INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>OCULAR THERAPEUTIX INC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>760273102</th>
      <td>REPARE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>REPARE THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>05492W103</th>
      <td>BCTG ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>303020101</th>
      <td>FS DEV CORP</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>87164F105</th>
      <td>SYNDAX PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>SYNDAX PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>55234L105</th>
      <td>LYRA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>LYRA THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>83422E105</th>
      <td>SOLID BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>SOLID BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>G3166W106</th>
      <td>ARYA SCIENCES ACQUISITION CO</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>G4411D109</th>
      <td>HEALTH SCIENCES ACQ CORP 2</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>36338D108</th>
      <td>GALERA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>GALERA THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>92337C104</th>
      <td>VERASTEM INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>VERASTEM INC</td>
      <td>30June20</td>
      <td>0.3</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>G31655114</th>
      <td>ARYA SCIENCES ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>ARYA SCIENCES ACQUISITION CORP</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>29668H708</th>
      <td>ESSA PHARMA INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>ESSA PHARMA INC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>98420X103</th>
      <td>X4 PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>X4 PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>690469101</th>
      <td>OVID THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>OVID THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>15117B202</th>
      <td>CELLDEX THERAPEUTICS INC NEW</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>CELLDEX THERAPEUTICS INC NEW</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>45249V107</th>
      <td>IMARA INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>IMARA INC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>702712100</th>
      <td>PASSAGE BIO INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>PASSAGE BIO INC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>60877T100</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>MOMENTA PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>1.6</td>
      <td>-1.6</td>
    </tr>
    <tr>
      <th>86150R107</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>STOKE THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.5</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>05337M104</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>AVADEL PHARMACEUTICALS PLC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>816212104</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>SELECTA BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>457669307</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>INSMED INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
  </tbody>
</table></body></html>.